Focus Partners Wealth’s GSK GSK Stock Holding History

Focus Partners Wealth’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.74M	Sell	90,484 -5,786	-6%	-$306K	﹤0.01%	985
2026 Q1	$5.32M	Buy	96,270 +29,344	+44%	+$1.59M	0.01%	919
2025 Q4	$3.29M	Buy	66,926 +18,127	+37%	+$845K	﹤0.01%	1119
2025 Q3	$2.07M	Buy	48,799 +8,776	+22%	+$343K	﹤0.01%	1002
2025 Q2	$1.54M	Buy	40,023 +357	+0.9%	+$13.6K	﹤0.01%	984
2025 Q1	$1.54M	Sell	39,666 -4,588	-10%	-$168K	﹤0.01%	922
2024 Q4	$1.5M	Buy	44,254 +9,235	+26%	+$332K	﹤0.01%	932
2024 Q3	$1.43M	Buy	35,019 +22,359	+177%	+$915K	﹤0.01%	856
2024 Q2	$487K	Buy	+12,660	New	+$533K	﹤0.01%	957

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Focus Partners Wealth's GSK Position: Q2 2026 in Review

Focus Partners Wealth reduced its GSK (GSK) stake by 6% in Q2 2026, selling an estimated $306K and leaving 90,484 shares worth $4.74M. The position accounts for ﹤0.01% of the portfolio, ranked #985.

Focus Partners Wealth first reported a position in GSK in Q2 2024 and has held it in 9 quarters since. The position peaked at $5.32M in Q1 2026. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Focus Partners Wealth held 90,484 shares of GSK worth $4.74M as of Q2 2026.
Focus Partners Wealth sold 5,786 GSK shares in Q2 2026, an estimated $306K.
GSK made up ﹤0.01% of Focus Partners Wealth's portfolio in Q2 2026, its #985 holding.
Focus Partners Wealth first reported a position in GSK in Q2 2024 and has held it in 9 quarters since.
Focus Partners Wealth's GSK position peaked at $5.32M in Q1 2026.
1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Focus Partners Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.